Unbelievable...., page-32

here is what happened. they postpone until the moment when Trofinetide will not guarantee resources to advance 2591. it is certain that in the meantime they will not lower themselves to accept downward conditions from anyone, much less distribute shares at bargain prices like the current ones. money for the normal administration and to advance the preclinical there are and expect better times from all points of view. although frankly frustrating with the great expectation in the short term, I believe this is the right attitude to guarantee a powerful future value for the shareholders when the favorable conditions materialize from the ongoing Acadia study. Furthermore, the regulatory procedure is also being pursued in Europe backed by the European patent granted and made official next week.nothing is lost, but only postponed to better times that there will inevitably be.